  |
Reflux and ulcer medications linked to kidney stones and chronic kidney disease |
|
Reflux and ulcer medications linked to kidney stones and chronic kidney disease
|
Darrell Miller | 12/04/16 |
Date:
December 04, 2016 07:59 AM
Author: Darrell Miller
(support@vitanetonline.com)
Subject: Reflux and ulcer medications linked to kidney stones and chronic kidney disease
A University in Rome has found information that links medications taken for acid reflux and heartburn to a higher incidence of kidney stones. By reviewing patient files, they found that patients who took proton pump inhibitors were at a 12% higher risk of developing kidney stones throughout their lives, and those who took histamine receptor-2 were at a 13% higher risk. They have stated that more research needs to be done, but any link between the medicine and kidney stones is cause for alarm.
Key Takeaways:
- "Use of PPIs and H2 blockers is associated with a small increase in risk of incident kidney stones
- chronic kidney disease that may arise after use of PPIs is secondary to incomplete recovery from acute kidney injury (AKI
- Reliance on AKI as a marker of potential adverse renal events in those treated with PPI is not sufficient,
"Proton pump inhibitors (PPIs) and histamine receptor-2 (H2) blockers are commonly used to reduce gastric acid production."
Reference:
https://www.sciencedaily.com/releases/2016/11/161118130351.htm
